HSBC Holdings
GMAB icon

HSBC Holdings’s Genmab GMAB Stock Holding History

HSBC Holdings’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,414
Closed -$220K – 2881
2020
Q4 		$220K Sell
5,414
-1,098
-17% -$41K ﹤0.01% 2753
2020
Q3 		$238K Sell
6,512
-2,370
-27% -$85.7K ﹤0.01% 2377
2020
Q2 		$301K Sell
8,882
-3,975
-31% -$108K ﹤0.01% 2121
2020
Q1 		$272K Buy
12,857
+42
+0.3% +$936 ﹤0.01% 2105
2019
Q4 		$286K Sell
12,815
-1,300
-9% -$28.4K ﹤0.01% 2585
2019
Q3 		$286K Buy
+14,115
New +$278K ﹤0.01% 2653

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

HSBC Holdings's GMAB Position: Q1 2021 in Review

HSBC Holdings sold out of Genmab (GMAB) in Q1 2021, closing a stake of 5,414 shares — an estimated $220K sold.

HSBC Holdings first reported a position in GMAB in Q3 2019 and held it in 6 quarters. The position peaked at $301K in Q2 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • HSBC Holdings reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • HSBC Holdings sold 5,414 Genmab shares in Q1 2021, an estimated $220K.
  • HSBC Holdings first reported a position in Genmab in Q3 2019 and held it in 6 quarters.
  • HSBC Holdings's Genmab position peaked at $301K in Q2 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.